Shalby Ltd. (IN:SHALBY)
:SHALBY
SHALBY Stock Chart & Stats
₹202.80
-₹4.08(-1.73%)
At close: 4:00 PM EST
₹202.80
-₹4.08(-1.73%)
Day’s Range― - ―
52-Week Range₹125.70 - ₹274.50
Previous CloseN/A
Volume74.36K
Average Volume (3M)71.31K
Market Cap
₹16.58B
Enterprise Value₹21.58B
Total Cash (Recent Filing)₹1.31B
Total Debt (Recent Filing)₹5.35B
Price to Earnings (P/E)310.4
Beta1.22
Next Earnings
Jun 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.59%
Share Statistics
EPS (TTM)0.16
Shares Outstanding108,009,766
10 Day Avg. Volume22,132
30 Day Avg. Volume71,313
Financial Highlights & Ratios
PEG Ratio-3.76
Price to Book (P/B)2.18
Price to Sales (P/S)1.99
P/FCF Ratio-21.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)6.1
Revenue Forecast (FY)₹13.21B
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthSustained top-line expansion indicates growing patient volumes and increased service uptake across the hospital network. Over 2-6 months this supports capacity utilization, improves bargaining leverage with payors and suppliers, and provides a foundation for reinvestment and scale-driven efficiencies.
Solid Equity BaseA high equity ratio signals a conservatively financed balance sheet, giving the company resilience against demand shocks and the flexibility to fund capex or acquisitions without excessive dilution. This strengthens long-term solvency and strategic optionality.
Specialized Multi-city Hospital NetworkDeep specialization in orthopaedics and a multi-city footprint create durable competitive advantages: referral ecosystems, clinical reputation, and steady demand from aging demographics. These structural features support pricing power for complex procedures and long-term patient volume stability.
Bears Say
Margin CompressionSharp contraction in gross and net margins signals rising cost pressures or weaker pricing power. Sustained margin erosion reduces retained earnings available for reinvestment, hurts return on equity, and impairs the company's capacity to fund growth from operating profits over the medium term.
Negative Free Cash FlowLarge negative free cash flow, driven by higher capex and weak operating cash conversion, creates persistent funding needs. Over months this can force reliance on external financing, restrict discretionary investment, and elevate liquidity and refinancing risk if cash generation does not recover.
Rising LeverageAn increase in leverage while profitability and cash flows weaken raises financial risk. Higher interest and principal commitments reduce margin of safety, limit strategic flexibility, and make the company more vulnerable to interest rate moves or revenue slowdowns in the medium term.
Shalby Ltd. News
SHALBY FAQ
What was Shalby Ltd.’s price range in the past 12 months?
Shalby Ltd. lowest stock price was ₹125.70 and its highest was ₹274.50 in the past 12 months.
What is Shalby Ltd.’s market cap?
Shalby Ltd.’s market cap is ₹16.58B.
When is Shalby Ltd.’s upcoming earnings report date?
Shalby Ltd.’s upcoming earnings report date is Jun 03, 2026 which is in 51 days.
How were Shalby Ltd.’s earnings last quarter?
Shalby Ltd. released its earnings results on Feb 11, 2026. The company reported ₹0.164 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.164.
Is Shalby Ltd. overvalued?
According to Wall Street analysts Shalby Ltd.’s price is currently Overvalued.
Does Shalby Ltd. pay dividends?
Shalby Ltd. pays a Annually dividend of ₹1.2 which represents an annual dividend yield of 0.59%. See more information on Shalby Ltd. dividends here
What is Shalby Ltd.’s EPS estimate?
Shalby Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shalby Ltd. have?
Shalby Ltd. has 108,009,766 shares outstanding.
What happened to Shalby Ltd.’s price movement after its last earnings report?
Shalby Ltd. reported an EPS of ₹0.164 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.184%.
Which hedge fund is a major shareholder of Shalby Ltd.?
Currently, no hedge funds are holding shares in IN:SHALBY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Shalby Ltd.
Shalby Limited operates multi-specialty hospitals primarily in India. The company offers arthroscopy, arthroplasty, cardiology, cardiothoracic and vascular surgery, cosmetic and aesthetic, dental cosmetic and implant ology, emergency medicine, endocrinology, endoscopy and laparoscopy, ENT surgery, gastroentero surgery, gastroenterology, general medicine and surgery, hair transplant, liver disease and transplant, and hip and knee joint replacement services. It also provides infectious disease, infertility and IVF, intensive and critical care, maxillofacial surgery, nephrology, neuro surgery, neurology, obesity surgery, obstetrics and gynecology, oncology, oncosurgery, ophthalmology and glaucoma, orthopedic and trauma, pediatric orthopedic, pathology and microbiology, pediatrics and neonatology, plastic surgery, pulmonology and chest, radiology and imaging, rheumatology, trauma, organ donation, and urosurgery services. The company operates 11 hospitals comprising aggregate capacity of 2,012 beds. In addition, it offers outpatient services through 50 outpatient clinics, as well as provides educational programs and fellowships for paramedical students and other healthcare professionals; and homecare health services, such as attendants, doctors, nursing, physiotherapy, pathology, pharmacy, and medical equipment, as well as conducts clinical research trials. It also operates in Kenya, Tanzania, Rwanda, Uganda, the United Arab Emirates, Bangladesh, Cambodia, Jakarta, Oman, Uzbekistan, Nepal, and internationally. The company was formerly known as Shalby Hospitals Limited and changed its name to Shalby Limited in February 2008. Shalby Limited was founded in 1994 and is headquartered in Ahmedabad, India.
Technical Analysis
Krsnaa Diagnostics Limited
―
Panacea Biotec Limited
―
SMS Pharmaceuticals Limited
―
TTK Healthcare Limited
―
Vimta Labs Limited
―